EMA — authorised 7 February 2019
- Marketing authorisation holder: ALEXION EUROPE SAS
- Status: approved
EMA authorised Ultomiris on 7 February 2019
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 7 February 2019.
ALEXION EUROPE SAS holds the EU marketing authorisation.